Opioid Tapering Guidelines

Introduction to Opioid Tapering

The American College of Physicians and other medical societies recommend tapering opioids through a slow, hyperbolic reduction of 10% of the current dose per month, with each new dose being 90% of the previous dose, combined with patient agreement, close monitoring, and adjunctive treatments for withdrawal symptoms 1, 2, 3

The American Medical Association recommends never abruptly discontinuing opioids in physically-dependent patients, as this constitutes unacceptable medical care and carries significant risks including overdose, psychological distress, and suicide 1, 2
Obtaining patient agreement and collaboration is crucial, as involuntary tapering is associated with poor outcomes including treatment dropout, emergency department utilization, and suicidal ideation 1, 2

For long-term opioid users, reduce the dose by 10% of the current dose per month or slower, using a hyperbolic taper where each new dose is 90% of the previous dose, to prevent disproportionately large final reductions that occur with linear tapers 3
The entire taper will likely take 6-12 months minimum, possibly years 3

Monitor patients for common physical withdrawal symptoms, including tremor, diaphoresis, agitation, insomnia, myoclonus, diffuse pain/hyperalgesia, hypertension, hyperthermia, cramping/diarrhea, pupillary dilation, and piloerection 2, 4
Consider adjunctive medications, such as clonidine or tizanidine for general withdrawal symptoms, trazodone for insomnia, gabapentin for anxiety and irritability, and loperamide for gastrointestinal discomfort 3, 4

There is insufficient evidence to advise opioid reduction in patients who show clear benefit from treatment, lack evident adverse effects, show no aberrant behavior, and have no major risks 2, 4
Consider switching to buprenorphine/naloxone for a controlled transition off full opioid agonists if tapering fails or the patient cannot tolerate withdrawal symptoms 3

Follow up with patients at least monthly during the taper, with more frequent contact during difficult phases, and screen for emerging psychiatric conditions, including depression, anxiety, and substance use disorders 3
Remain alert for unmasked conditions, such as anxiety, depression, or opioid use disorder, and advise patients of increased overdose risk if they return to previous doses after tolerance is lost 3

Avoid using a fixed timeline for tapering, as the taper must be adjusted based on the individual's response, not a predetermined schedule 1
Do not make "cold referrals" to other clinicians during the taper without ensuring they have agreed to accept the patient's care 1
Tapering solely based on dose thresholds is not recommended, as exceeding recommended opioid dose limitations is not in itself a sufficient reason to taper if the patient is benefiting without adverse effects 2
Failing to address pain management and abandoning patients who struggle are common pitfalls to avoid, and maintaining the therapeutic relationship is crucial 1, 2

Integrate comprehensive pain management strategies, including behavioral therapies, physical therapy and exercise, non-opioid analgesics, and interventional pain procedures when appropriate 1, 4